IP Library Granted Patent US 12,213,845
Granted Patent B2
US 12,213,845 · App. 18/501,913 · Granted Feb 4, 2025

Ultrasound guided femoral artery access system (UFAAS) and method to enhance brain perfusion during neuroprotective CPR

Inventor: Keith G. Lurie (Minneapolis, MN)
Assignee: Resuscitation Innovations LLC
A61B90/37A61H31/007A61B2090/378
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,213,845
App. No.
18/501,913
Granted
Feb 4, 2025
Kind
B2
Abstract

A handheld ultrasound guiding system for the transcutaneous delivery of a needle into blood vessel that can be used to then deliver a guidewire, the battery powered light-weight device consisting of a phased array ultrasound generator, a transducer probe, a screen, computer processor that is mechanically coupled to a needle holder mounted at an angle to the ultrasound probe, the needle is mounted such that it can be advanced into a target blood vessel that is being visualized real-time by the ultrasound probe.

Claims (39)

1. A method of performing cardiovascular resuscitation, comprising:

elevating an individual's head, shoulders, and heart relative to the individual's lower body while the individual's lower body remains generally aligned with a horizontal plane;

compressing the individual's chest while the individual's head, shoulders, and heart are elevated;

regulating an intrathoracic pressure of the individual while the individual's head, shoulders, and heart are elevated relative to the lower body; and

performing REBOA on the individual by positioning an intra-aortic balloon in the individual's aorta using an ultrasound-guided cannulation device and inflating the intra-aortic balloon.

2. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

performing active compression decompression cardiopulmonary resuscitation on the individual while the individual is in a supine position in general alignment with the horizontal plane prior to elevating the individual's head, shoulders, and heart.

3. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

actively decompressing the individual's chest between each chest compression.

4. The method of performing cardiovascular resuscitation of claim 1 , wherein:

regulating the intrathoracic pressure comprises interfacing an impedance threshold device with the individual's airway.

5. The method of performing cardiovascular resuscitation of claim 1 , wherein:

elevating the individual's head, shoulders, and heart comprises elevating the individuals' head to a height of between 10 cm and 30 cm above the horizontal plane and elevating the individual's heart to a height of between 5 cm to 15 cm above the horizontal plane.

6. The method of performing cardiovascular resuscitation of claim 1 , wherein:

REBOA is performed on the individual while the individual's head, shoulders, and heart are elevated.

7. The method of performing cardiovascular resuscitation of claim 1 , wherein:

positioning the intra-aortic balloon in the individual's aorta using the ultrasound-guided cannulation device comprises:

locating a femoral artery of the individual using a display device of the ultrasound-guided cannulation device;

inserting a needle into the femoral artery;

advancing a guidewire into the femoral artery via a hollow bore of the needle; and

advancing the intra-aortic balloon to the aorta using the guidewire.

8. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

keeping the intra-aortic balloon in an inflated state for a predetermined period of time after a return of circulation to the individual.

9. The method of performing cardiovascular resuscitation of claim 8 , wherein:

the predetermined period of time is up to one hour.

10. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

deflating the intra-aortic balloon after a return of circulation to the individual upon determining that a physiological measurement of the individual has reached a particular value.

11. The method of performing cardiovascular resuscitation of claim 10 , wherein:

the physiological measurement comprises a blood pressure of the individual.

12. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

deflating the intra-aortic balloon after a return of circulation to the individual, wherein one or both of a timing and a rate of deflation is controlled using a closed loop feedback system with one or more physiologic measurements.

13. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

deflating the intra-aortic balloon after a return of circulation to the individual, wherein one or both of a timing and a rate of deflation is controlled using an open loop feedback system with one or more physiologic measurements.

14. The method of performing cardiovascular resuscitation of claim 1 , further comprising:

deflating the intra-aortic balloon after a return of circulation to the individual, wherein deflation of the intra-aortic balloon is coordinated with a change in elevation of the individual's head, shoulders, and heart.

15. The method of performing cardiovascular resuscitation of claim 14 , wherein:

coordination of the deflation of the intra-aortic balloon is performed by monitoring blood flow to the individual's brain.

16. The method of performing cardiovascular resuscitation of claim 15 , wherein:

monitoring blood flow to the individual's brain is performed using one or both of a measurement of end tidal CO 2 and a measurement of cerebral oximetry.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2024
From: VITALINC LLC
To: RESUSCITATION INNOVATIONS LLC
Reel/Frame 068229/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2023
From: LURIE, KEITH G
To: VITALINC LLC
Reel/Frame 065499/0091 →
Continuity (2)
Provisional Application 63382231 · Nov 3, 2022
Related Publication 20240148465A1 · May 9, 2024
References Cited (27)
US 9707152B2 · Lurie et al. · 2017 [cited by applicant]
US 9750661B2 · Lurie et al. · 2017 [cited by applicant]
US 9801782B2 · Lurie et al. · 2017 [cited by applicant]
US 10092481B2 · Lurie · 2018 [cited by applicant]
US 10245209B2 · Lurie · 2019 [cited by applicant]
US 10350137B2 · Lurie et al. · 2019 [cited by applicant]
US 10406068B2 · Lurie et al. · 2019 [cited by applicant]
US 10406069B2 · Lurie et al. · 2019 [cited by applicant]
US 10667987B2 · Lurie · 2020 [cited by applicant]
US 11020314B2 · Lurie · 2021 [cited by applicant]
US 11096861B2 · Lurie · 2021 [cited by applicant]
US 11246794B2 · Lurie · 2022 [cited by applicant]
US 11259988B2 · Lurie et al. · 2022 [cited by applicant]
US 20030233046A1 · Ferguson et al. · 2003 [cited by applicant]
US 20140048061A1 · Yannopoulos et al. · 2014 [cited by applicant]
US 20140073910A1 · Munrow et al. · 2014 [cited by applicant]
US 20140363391A1 · Yannopoulos et al. · 2014 [cited by applicant]
US 20190159963A1 · Lurie · 2019 [cited by applicant]
US 20200230391A1 · Burkholz et al. · 2020 [cited by applicant]
US 20210000685A1 · Lurie · 2021 [cited by applicant]
US 20210308007A1 · Lurie · 2021 [cited by examiner]
US 20210322264A1 · Lurie · 2021 [cited by applicant]
US 20220061806A1 · Burkholz · 2022 [cited by applicant]
US 20220265508A1 · Lurie et al. · 2022 [cited by applicant]
US 20220313211A1 · Eltorai et al. · 2022 [cited by applicant]
PCT/US2023/078725, “Invitation to Pay Additional Fees and, Where Applicable, Protest Fee”, Feb. 23, 2024, 2 pages. [cited by applicant]
PCT/US2023/078725, “International Search Report and Written Opinion”, Apr. 19, 2024, 13 pages. [cited by applicant]